Automated Evaluation of Female Pelvic Organ Descent on Transperineal Ultrasound: Model Development and Validation
International Urogynecology Journal · 2025
DOI: 10.1007/s00192-025-06211-0 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift International Urogynecology Journal, 2025. Verfasst von Shuangyu Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, China. Hauptthemen laut MEDLINE: Pelvic Organ Prolapse, Deep Learning. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Guangzhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
INTRODUCTION AND HYPOTHESIS: Transperineal ultrasound (TPUS) is a widely used tool for evaluating female pelvic organ prolapse (POP), but its accurate interpretation relies on experience, causing diagnostic variability. This study aims to develop and validate a multi-task deep learning model to automate POP assessment using TPUS images. METHODS: TPUS images from 1340 female patients (January-June 2023) were evaluated by two experienced physicians. The presence and severity of cystocele, uterine prolapse, rectocele, and excessive mobility of perineal body (EMoPB) were documented. After preprocessing, 1072 images were used for training and 268 for validation. The model used ResNet34 as the feature extractor and four parallel fully connected layers to predict the conditions. Model performance was assessed using confusion matrix and area under the curve (AUC). Gradient-weighted class activation mapping (Grad-CAM) visualized the model's focus areas. RESULTS: The model demonstrated strong diagnostic performance, with accuracies and AUC values as follows: cystocele, 0.869 (95% CI, 0.824-0.905) and 0.947 (95% CI, 0.930-0.962); uterine prolapse, 0.799 (95% CI, 0.746-0.842) and 0.931 (95% CI, 0.911-0.948); rectocele, 0.978 (95% CI, 0.952-0.990) and 0.892 (95% CI, 0.849-0.927); and EMoPB, 0.869 (95% CI, 0.824-0.905) and 0.942 (95% CI, 0.907-0.967). Grad-CAM heatmaps revealed that the model's focus areas were consistent with those observed by human experts. CONCLUSIONS: This study presents a multi-task deep learning model for automated POP assessment using TPUS images, showing promising efficacy and potential to benefit a broader population of women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasound, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, China.
- School of Computer Science and Engineering, Sun Yat-Sen University, Guangzhou, Guangdong Province, China.
- School of Computer Science and Engineering, Sun Yat-Sen University, Guangzhou, Guangdong Province, China. wangruix5@mail.sysu.edu.cn.
- Department of Ultrasound, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, China. zhxinl@mail.sysu.edu.cn.
ORCID-Profile: Xinling Zhang
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Guangzhou Municipal Science and Technology Bureau
Zitieren
APA
Wu, S., Wu, J., Xu, Y., Tan, J., Wang, R., & Zhang, X. (2025). Automated Evaluation of Female Pelvic Organ Descent on Transperineal Ultrasound: Model Development and Validation. International Urogynecology Journal. https://doi.org/10.1007/s00192-025-06211-0
Vancouver
Wu S, Wu J, Xu Y, Tan J, Wang R, Zhang X. Automated Evaluation of Female Pelvic Organ Descent on Transperineal Ultrasound: Model Development and Validation. International Urogynecology Journal. 2025. doi:10.1007/s00192-025-06211-0
BibTeX
@article{Wu2025,
author = {Wu, Shuangyu and Wu, Jiawei and Xu, Yuteng and Tan, Jiantao and Wang, Ruixuan and Zhang, Xinling},
title = {Automated Evaluation of Female Pelvic Organ Descent on Transperineal Ultrasound: Model Development and Validation},
journal = {International Urogynecology Journal},
year = {2025},
doi = {10.1007/s00192-025-06211-0}
}
EUVIMED